Valiant Laboratories

Valiant Laboratories Earnings Yield

The Earnings Yield of Valiant Laboratories (VALIANTLAB.NS) as of Nov 4, 2026 is -0.90 %. In the previous year, Earnings Yield was -0.61 % — a change of 48.46% (lower).

Earnings Yield

-0.90 %

YoY

48.46%

Last updated:

Earnings Yield of Valiant Laboratories is 2026 -0.90 % . Earnings Yield of Valiant Laboratories was 2025 -0.61 % . It decreases by 48.46% lower compared to the previous year.

The Valiant Laboratories Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2021
8.46 INR
Jan 1, 2022
7.61 INR
Jan 1, 2023
8.02 INR
Jan 1, 2024
0.09 INR
Jan 1, 2025
-0.61 INR
Jan 1, 2026
-0.90 INR
The Valiant Laboratories Earnings Yield history
YEAREarnings YieldYoY
-0.90 %+48.46%
-0.61 %-788.74%
0.09 %-98.90%
8.02 %+5.46%
7.61 %-10.12%
8.46 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Laboratories Stock analysis

What does Valiant Laboratories do? Valiant Laboratories Ltd manufactures paracetamol API/bulk drug for pharmaceutical applications, targeting medical conditions such as headache, muscle ache, arthritis, back ache, toothache, cold, and fever. The company operates a single manufacturing facility at Tarapur industrial estate, approximately 150 km from Nhava Sheva Port (JNPT), producing specialty chemicals and pharma intermediates for domestic and international markets. Its subsidiary, VALIANT ADVANCED SCIENCES PRIVATE LIMITED, supports the company's operations in the pharmaceutical sector. The firm's primary revenue comes from selling paracetamol API and specialty chemicals to pharmaceutical companies and distributors globally. Manufacturing focuses on high-demand applications like pain relief and fever treatment, with products distributed across India and abroad. The company leverages its Tarapur facility's proximity to Nhava Sheva Port for efficient export logistics. Valiant Laboratories Ltd serves the pharmaceutical industry by supplying essential active ingredients, particularly paracetamol, which is widely used in over-the-counter medications. The company's manufacturing capabilities for specialty chemicals and pharma intermediates cater to both domestic and international clients seeking reliable API sources. Its single-location production model ensures focused resource allocation for consistent output quality. Valiant Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Laboratories stock

Earnings Yield of Valiant Laboratories is -0.90 % in 2026.

Earnings Yield of Valiant Laboratories changed from -0.61 % to -0.90 %, representing a 48.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield Valiant Laboratories since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's Valiant Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Valiant Laboratories

All Key Metrics — Valiant Laboratories